null

SMILES Nc1nonc1-c1nc2ccccc2n1CC1CC1

InChI Key InChIKey=LLDVRUBUBPSOMY-UHFFFAOYSA-N

PDB links: 1 PDB ID matches this monomer.

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50310459   

TargetRibosomal protein S6 kinase beta-1(Homo sapiens (Human))
Vertex Pharmaceuticals, Inc.

Curated by ChEMBL
LigandPNGBDBM50310459(4-(1-(cyclopropylmethyl)-1H-benzo[d]imidazol-2-yl)...)copy SMILEScopy InChI
Affinity DataKi:  12nMAssay Description:Inhibition of p70S6K assessed as decrease in NADH absorbance at 340 nm in the presence ofMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KP8287PubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Vertex Pharmaceuticals, Inc.

Curated by ChEMBL
LigandPNGBDBM50310459(4-(1-(cyclopropylmethyl)-1H-benzo[d]imidazol-2-yl)...)copy SMILEScopy InChI
Affinity DataKi:  290nMAssay Description:Inhibition of GSK3beta assessed as decrease in NADH absorbance at 340 nm in the presence ofMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KP8287PubMed
TargetRho-associated protein kinase 1(Homo sapiens (Human))
Vertex Pharmaceuticals, Inc.

Curated by ChEMBL
LigandPNGBDBM50310459(4-(1-(cyclopropylmethyl)-1H-benzo[d]imidazol-2-yl)...)copy SMILEScopy InChI
Affinity DataKi:  360nMAssay Description:Inhibition of ROCK1 assessed as decrease in NADH absorbance at 340 nm in the presence ofMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KP8287PubMed
TargetcAMP-dependent protein kinase catalytic subunit alpha(Homo sapiens (Human))
Vertex Pharmaceuticals, Inc.

Curated by ChEMBL
LigandPNGBDBM50310459(4-(1-(cyclopropylmethyl)-1H-benzo[d]imidazol-2-yl)...)copy SMILEScopy InChI
Affinity DataKi:  380nMAssay Description:Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence ofMore data for this Ligand-Target Pair